China News Service, May 6 (Xinhua) According to comprehensive foreign media reports, the US Food and Drug Administration (FDA) announced on the 5th that it will limit the range of people who can receive the Johnson & Johnson vaccine due to the risk of rare blood clots in the vaccine.
According to reports, the FDA will limit the Johnson & Johnson vaccine to individuals 18 years of age and older who are not eligible or unable to obtain other authorized new crown vaccines, and those who do not plan to receive other new crown vaccines.
The FDA said 60 cases of blood clots have been identified following the J&J vaccine, including nine deaths.